Tahoe Therapeutics Selects Parse Biosciences’ GigaLab to Generate 300 Million Single Cell…
Business Wire IndiaParse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that Tahoe Therapeutics has selected Parse's GigaLab to generate data for its upcoming 300M cell project.…